Revolution Medicines Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Revolution Medicines Inc
TickerRVMDW
CIK #0001628171
CUSIP76155X118
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address700 Saginaw Dr, Redwood City, CA 94063
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Revolution Medicines Inc 2019-11-15 100.3 M Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001628171] 10-K
[0001628171] 10-Q
[0001628171] 3
[0001628171] 4
[0001628171] 8-K
[0001628171] D
[0001628171] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
FMR LLC Revolution Medicines Inc [2025-11-05] 0.0
Baker Bros Advisors LP Revolution Medicines Inc [2025-08-14] 0.0
Farallon Capital Partners LP Revolution Medicines Inc [2025-05-15] 0.0
Janus Henderson Group PLC Revolution Medicines Inc [2025-02-14] 0.0
Farallon Capital Partners LP Revolution Medicines Inc [2023-11-09] 0.3
Biotechnology Value Fund L P Revolution Medicines Inc [2023-06-30] 4.4
EcoR1 Capital LLC Revolution Medicines Inc [2023-01-23] 5.0
BB Biotech AG Revolution Medicines Inc [2022-09-30] 5.2
EcoR1 Capital LLC Revolution Medicines Inc [2022-06-27] 5.8
Wellington Management Group LLP Revolution Medicines Inc [2022-02-04] 6.12
Cormorant Asset Management LP Revolution Medicines Inc [2021-05-19] 2.8
Biotechnology Value Fund L P Revolution Medicines Inc [2021-05-17] 2.7
Column Group III LP Revolution Medicines Inc [2021-02-16] 2.3
Third Rock Ventures III LP Revolution Medicines Inc [2021-02-16] 2.9
Sanofi Revolution Medicines Inc [2021-02-11] 4.6
Vanguard Group Inc Revolution Medicines Inc [2021-02-10] 6.08
BlackRock Inc Revolution Medicines Inc [2021-02-02] 5.3
FMR LLC Revolution Medicines Inc [2020-04-10] 0.0
Cormorant Asset Management LP Revolution Medicines Inc [2020-02-24] 2.7
Flynn James E Revolution Medicines Inc [2020-02-18] 1.4
Boxer Capital LLC Revolution Medicines Inc [2020-02-13] 0.0
Form 3/4/5 Filer 2011 - 2026
Patel Sushil
Revolution Medicines Inc
Anders Jack
Borisy Alexis
Anderson Elizabeth M
Horning Sandra
Clyburn Frank
Borellini Flavia
Kim Lorence H
Kelsey Stephen Michael
Mancini Anthony
Goldsmith Mark A
Cislini Jeff
Horn Margaret A
Sandler Alan B
Wang Xiaolin
Wei Lin
Schroeder Thilo
Weber Barbara
Schmidt Eric Thomas
Exter Neil
Third Rock Ventures III LP
Third Rock Ventures GP III LP
TRV GP III LLC
Tepper Robert I
Miller Vincent A
Third Rock Ventures II LP
Starr Kevin P
Levin Mark J
Third Rock Ventures GP II LP
TRV GP II LLC
Svennilson Peter
Ponoi II Management LLC
Ponoi Management LLC
Column Group III-A LP
Kutzkey Tim
Ponoi Capital LP
Column Group III GP LP
Column Group III LP
Ponoi Capital II LP
Goeddel David V
Third Rock Ventures GP IV LP
Third Rock Ventures IV LP
TRV GP IV LLC
Deerfield Private Design Fund IV LP
Deerfield Management Company LP
Deerfield Capital LP
Deerfield Partners LP
Flynn James E
Deerfield Mgmt IV LP
Lasky Laurence
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Mancini Anthony
Common Stock
2026-03-25 Sell 21,086 $95.49 2,013,502
Mancini Anthony
Common Stock
2026-03-25 Option exercise 37,450 $33.62 1,259,069
Mancini Anthony
Common Stock
2026-03-25 Sell 3,128 $94.16 294,532
Mancini Anthony
Common Stock
2026-03-25 Sell 1,800 $93.22 167,796
Mancini Anthony
Stock Option (Right to Buy) · derivative
2026-03-25 Option exercise 37,450 $0.00
Mancini Anthony
Common Stock
2026-03-25 Sell 11,036 $96.43 1,064,201
Mancini Anthony
Common Stock
2026-03-25 Sell 400 $97.21 38,884
Cislini Jeff
Common Stock
2026-03-19 Sell 1,163 $97.44 113,323
Wei Lin
Common Stock
2026-03-17 Sell 2,073 $99.48 206,222
Cislini Jeff
Common Stock
2026-03-17 Sell 1,795 $99.48 178,567
Goldsmith Mark A
Common Stock
2026-03-17 Sell 12,871 $99.48 1,280,407
Anders Jack
Common Stock
2026-03-17 Sell 2,753 $99.48 273,868
Horn Margaret A
Common Stock
2026-03-17 Sell 4,583 $99.48 455,917
Kelsey Stephen Michael
Common Stock
2026-03-17 Sell 4,302 $99.48 427,963
Wang Xiaolin
Common Stock
2026-03-17 Sell 2,010 $99.48 199,955
Anderson Elizabeth M
Common Stock
2026-03-04 Gift 15,000 $0.00
Anderson Elizabeth M
Common Stock
2026-03-04 Gift 15,000 $0.00
Goldsmith Mark A
Common Stock
2026-03-02 Sell 800 $102.00 81,600
Goldsmith Mark A
Common Stock
2026-03-02 Sell 600 $100.19 60,114
Goldsmith Mark A
Stock Option (Right to Buy) · derivative
2026-03-02 Option exercise 30,000 $0.00
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 24 10,151,273
2025-12-31 25 8,804,703
2025-09-30 23 8,153,258
2025-06-30 25 8,164,915
2025-03-31 26 7,785,761
2024-12-31 27 8,009,234
2024-09-30 29 7,452,561
2024-06-30 28 7,472,953
2024-03-31 27 7,497,622
2023-12-31 25 5,516,952
Form 13F Holdings
Firm Period DFND Voting Shares
DLK Investment Management LLC [2026-06-30] SOLE 77,000 77,000
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com